Search results
19 views
“Cyclobenzaprine Hydrochloride”
26 results across 2 regulatory databases
Advertise your brands to the growing global pharmaceutical community of industry leaders and decision makers.
Advertise Here
Reach qualified buyersBoost your visibility among pharma sourcing professionals and potential buyers.
- Grow your business with qualified leads
- GDS reports on your ad performance
- Targeted to this product's audience
- Direct enquiries from buyers
- Visibility to pharma professionals
Japan Drug Master Files 1
JDMFDF
Dipharma Francis S. r. l.
Product
Cyclobenzaprine hydrochloride
MF registration number
306MF10003
Registration category
APIs
Initial registration
2024-01-11
Latest registration
2024-01-11
Registered address
Via Bissone, 5, 20021-Baranzate, Milano, Italy
National Drug Code 26
US FDA NDCAP
Adare Pharmaceuticals, Inc.
NDC
59917-090
Nonproprietary Name
Cyclobenzaprine Hydrochloride
Dosage Form
CAPSULE, EXTENDED RELEASE
Product Type
DRUG FOR FURTHER PROCESSING
Strength
15 mg/1
Substance
CYCLOBENZAPRINE HYDROCHLORIDE
Start Marketing Date
2009-05-12
End Marketing Date
0000-00-00
DEA Schedule
-
Certified Through
2026-12-31
Sponsored
Advertise Here
Connect with buyers actively searching for Cyclobenzaprine Hydrochloride
Position your company at the top of relevant search results and generate qualified enquiries from verified pharmaceutical buyers. 19 views on this search.
Limited-Time Offer
Advertise on PharmaJungle - Free for 30 Days
Get your company in front of buyers, manufacturers, and sourcing professionals on PharmaJungle - completely free for your first 30 days.
- 30 days of free advertising
- Visibility across all pages
- Performance report with ad insights
- No setup or registration fee
Exclusive introductory offer for new advertisers
Related databases
2 of 6 have records
CEP Certificates
No records
Japan DMF
1
KDMF Registrations
No records
National Drug Code
26
FDA Inspections
No records
Eudra GMP
No records